Your browser doesn't support javascript.
loading
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
Beach, Callum; MacLean, David; Majorova, Dominika; Melemenidis, Stavros; Nambiar, Dhanya K; Kim, Ryan K; Valbuena, Gabriel N; Guglietta, Silvia; Krieg, Carsten; Darvish-Damavandi, Mahnaz; Suwa, Tatsuya; Easton, Alistair; Hillson, Lily Vs; McCulloch, Ashley K; McMahon, Ross K; Pennel, Kathryn; Edwards, Joanne; O'Cathail, Sean M; Roxburgh, Campbell S; Domingo, Enric; Moon, Eui Jung; Jiang, Dadi; Jiang, Yanyan; Zhang, Qingyang; Koong, Albert C; Woodruff, Trent M; Graves, Edward E; Maughan, Tim; Buczacki, Simon Ja; Stucki, Manuel; Le, Quynh-Thu; Leedham, Simon J; Giaccia, Amato J; Olcina, Monica M.
Afiliación
  • Beach C; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • MacLean D; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Majorova D; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Melemenidis S; Department of Radiation Oncology, Stanford University, Stanford, California, USA.
  • Nambiar DK; Department of Radiation Oncology, Stanford University, Stanford, California, USA.
  • Kim RK; Department of Radiation Oncology, Stanford University, Stanford, California, USA.
  • Valbuena GN; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Guglietta S; Department of Regenerative Medicine and Cell Biology.
  • Krieg C; Hollings Cancer Center, and.
  • Darvish-Damavandi M; Hollings Cancer Center, and.
  • Suwa T; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Easton A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Hillson LV; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • McCulloch AK; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • McMahon RK; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Pennel K; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • O'Cathail SM; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Roxburgh CS; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Domingo E; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Moon EJ; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Jiang D; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Jiang Y; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Zhang Q; Department of Radiation Oncology, Stanford University, Stanford, California, USA.
  • Koong AC; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Woodruff TM; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Graves EE; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Maughan T; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Buczacki SJ; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Stucki M; Department of Radiation Oncology, Stanford University, Stanford, California, USA.
  • Le QT; Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Leedham SJ; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
  • Giaccia AJ; Department of Gynecology, University of Zurich, Schlieren, Switzerland.
  • Olcina MM; Department of Radiation Oncology, Stanford University, Stanford, California, USA.
J Clin Invest ; 133(23)2023 Dec 01.
Article en En | MEDLINE | ID: mdl-37824211
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Complemento / Complemento C5a Límite: Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Complemento / Complemento C5a Límite: Humans Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido